Literature DB >> 391328

Extrapyramidal syndrome with sodium valproate.

A Lautin, M Stanley, B Angrist, S Gershon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391328      PMCID: PMC1596789          DOI: 10.1136/bmj.2.6197.1035-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Muscimol: GABA agonist therapy in schizophrenia.

Authors:  C A Tamminga; J W Crayton; T N Chase
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

2.  Letter: Bacloffen in schizophrenia.

Authors:  K L Davis; L E Hollister; P A Berger
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

3.  The relationship between parkinsonism and tardive dyskinesia.

Authors:  J Gerlach
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

4.  gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.

Authors:  D P Van Kammen
Journal:  Am J Psychiatry       Date:  1977-02       Impact factor: 18.112

  4 in total
  2 in total

Review 1.  Valproate-Associated Parkinsonism: A Critical Review of the Literature.

Authors:  Florian Brugger; Kailash P Bhatia; Frank M C Besag
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

2.  Disabling tremor induced by long-term use of sodium valproate and lamotrigine: Case report.

Authors:  Zhong-Fang He; Jun Chen; Chao-Ning Zhou; Zhi Rao; Xiao-Hua Wang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.